Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Sep 10, 2026, 10:27 AM EDT - Market open
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $83.22 million as of September 10, 2026. Its market cap has increased by 80.87% in one year.
Market Cap
83.22M
Enterprise Value
78.18M
1-Year Change
80.87%
Ranking
Category
Stock Price
$1.21
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $83.22M, a decrease of -59.85%. That is a compound annual growth rate of -29.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 83.22M | 81.99% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 87.55M |
| Kalaris Therapeutics | 87.36M |
| Cardiff Oncology | 86.74M |
| MediciNova | 86.14M |
| OS Therapies | 84.64M |
| iBio, Inc. | 83.92M |
| MAIA Biotechnology | 80.90M |
| Gain Therapeutics | 80.74M |